BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9809464)

  • 1. D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling?
    Bell D; McDermott BJ
    Gen Pharmacol; 1998 Nov; 31(5):689-96. PubMed ID: 9809464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is PP56 (D-myo-inositol-1,2,6-trisphosphate) an antagonist at neuropeptide Y receptors?
    Feth F; Erdbrügger W; Rascher W; Michel MC
    Life Sci; 1993; 52(23):1835-44. PubMed ID: 8388981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding.
    Heilig M; Edvinsson L; Wahlestedt C
    Eur J Pharmacol; 1991 Dec; 209(1-2):27-32. PubMed ID: 1667639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic localization and characterization of [3H]alpha-trinositol (1D-myo-inositol 1,2,6-trisphosphate) binding sites in human and mammalian tissues.
    Walsh DA; Mapp PI; Polak JM; Blake DR
    J Pharmacol Exp Ther; 1995 Apr; 273(1):461-9. PubMed ID: 7714802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog.
    Potter EK; Edvinsson L; Gustafsson T
    Eur J Pharmacol; 1992 Oct; 221(2-3):307-14. PubMed ID: 1426007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries.
    Edvinsson L; Adamsson M; Jansen I
    Neuropeptides; 1990 Oct; 17(2):99-105. PubMed ID: 2280824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission.
    Sun XY; Edvinsson L; Yoo H; Wahlestedt C; Hedner T
    J Cardiovasc Pharmacol; 1995 May; 25(5):696-704. PubMed ID: 7630147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic effect of D-myo-inositol-1,2,6-trisphosphate (PP56) on neuropeptide Y-induced vasoconstriction in the feline dental pulp.
    Kim SK; Ang L; Hsu YY; Dörscher-Kim J; Kim S
    Arch Oral Biol; 1996; 41(8-9):791-8. PubMed ID: 9022916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of D-myo-inositol-1,2,6-trisphosphate on glucose-stimulated insulin secretion in the mouse.
    Ahrén B
    Neuropeptides; 1992 Mar; 21(3):163-6. PubMed ID: 1630602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
    Schwieler JH; Hjemdahl P
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
    Sun XY; Dahlöf C; Edvinsson L; Hedner T
    Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats.
    Sun XY; Feng QP; Zhao X; Edvinsson L; Hedner T
    Life Sci; 1995; 57(12):1197-211. PubMed ID: 7674809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
    Sun XY; Edvinsson L; Hedner T
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal alpha-trinositol facilitates the flexor reflex but does not block the depressive effect of neuropeptide Y.
    Xu XJ; Wiesenfeld-Hallin Z
    Eur J Pharmacol; 1995 Jan; 272(2-3):219-22. PubMed ID: 7713166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of neuropeptide Y-induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol-1.2.6-trisphosphate (PP56) in rabbit femoral arteries.
    Adamsson M; Edvinsson L
    Neuropeptides; 1991 May; 19(1):13-6. PubMed ID: 1891070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
    Adamsson M; Fallgren B; Edvinsson L
    Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Sun X; Edvinsson L; Hedner T
    J Hypertens; 1993 Sep; 11(9):935-43. PubMed ID: 8254175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral hyperalgesia in experimental neuropathy: exacerbation by neuropeptide Y.
    Tracey DJ; Romm MA; Yao NN
    Brain Res; 1995 Jan; 669(2):245-54. PubMed ID: 7712180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.